Thermo Fisher Scientific to issue up to $1.05 billion of convertibles

By Angela McDaniels

Tacoma, Wash., June 5 - Thermo Fisher Scientific Inc. plans to issue up to $1.05 billion of mandatorily convertible debt, preference shares or other equity-linked securities, according to an 8-K filing with the Securities and Exchange Commission.

The proceeds will be used to help fund the company's acquisition of Life Technologies Corp.

The purchase price for the acquisition is $13.6 billion. The company plans to finance the remainder of the purchase price with a $2.2 billion public offering of common stock, a $5 billion term loan, debt securities and cash on hand.

The company expects the amount of the convertibles will be reduced to the extent that the underwriters of the stock offering exercise their $330 million over-allotment option.

Thermo Fisher is a science technology company based in Waltham, Mass.

Life Technologies is a Carlsbad, Calif.-based life sciences company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.